drugset / Trial / NCT07680023

Amnion Membrane Powder Mohs Study

NCT07680023 ↗

Phase 1 Not yet recruiting 20 enrolled Wake Forest University Health Sciences
Non-randomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this research study is to test the safety of the amnion membrane powder to see if it improves wound healing in patients undergoing Mohs surgery on the scalp.

Timeline

Start
2026-10
Primary completion
2027-10
Completion
2027-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Amnion Membrane Powder Other / unclassified 0.26 unknown Topical

Indications

No indication recorded.